BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34136084)

  • 21. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.
    Bunaciu RP; Jensen HA; MacDonald RJ; LaTocha DH; Varner JD; Yen A
    PLoS One; 2015; 10(8):e0135668. PubMed ID: 26287494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression.
    Jensen HA; Yourish HB; Bunaciu RP; Varner JD; Yen A
    FEBS Open Bio; 2015; 5():789-800. PubMed ID: 26566473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle.
    Wightman J; Roberson MS; Lamkin TJ; Varvayanis S; Yen A
    Mol Cancer Ther; 2002 May; 1(7):493-506. PubMed ID: 12479267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells.
    Katagiri K; Yokoyama KK; Yamamoto T; Omura S; Irie S; Katagiri T
    J Biol Chem; 1996 May; 271(19):11557-62. PubMed ID: 8626717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoic acid, bromodeoxyuridine, and the Δ205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation.
    Yen A; Lin DM; Lamikin TJ; Varvayanis S
    In Vitro Cell Dev Biol Anim; 2004 Jul; 40(7):216-41. PubMed ID: 27520281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. retinoic acid, bromodeoxyuridine, and the Delta 205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation.
    Yen A; Lin DM; Lamkin TJ; Varvayanis S
    In Vitro Cell Dev Biol Anim; 2004; 40(7):216-41. PubMed ID: 15638704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
    van Gils N; Verhagen HJMP; Smit L
    Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation.
    Miranda MB; Redner RL; Johnson DE
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3081-90. PubMed ID: 18065491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
    Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
    Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.
    Classen CF; Teigler-Schlegel A; Röttgers S; Reinhardt D; Döhner K; Debatin KM
    Ann Hematol; 2005 Nov; 84(12):774-80. PubMed ID: 16044313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
    Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.
    Yen A; Sturgill R; Varvayanis S
    Cancer Res; 1997 May; 57(10):2020-8. PubMed ID: 9158000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depleting interferon regulatory factor-1(IRF-1) with CRISPR/Cas9 attenuates inducible oxidative metabolism without affecting RA-induced differentiation in HL-60 human AML cells.
    Zhu K; Yue J; Yen A
    FASEB Bioadv; 2020 Jun; 2(6):354-364. PubMed ID: 32617521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
    Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro.
    Sakashita A; Kizaki M; Pakkala S; Schiller G; Tsuruoka N; Tomosaki R; Cameron JF; Dawson MI; Koeffler HP
    Blood; 1993 Feb; 81(4):1009-16. PubMed ID: 8427982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.
    Shen M; Yen A
    Cancer Res; 2008 Nov; 68(21):8761-9. PubMed ID: 18974118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of protein kinase C delta by all-trans-retinoic acid.
    Kambhampati S; Li Y; Verma A; Sassano A; Majchrzak B; Deb DK; Parmar S; Giafis N; Kalvakolanu DV; Rahman A; Uddin S; Minucci S; Tallman MS; Fish EN; Platanias LC
    J Biol Chem; 2003 Aug; 278(35):32544-51. PubMed ID: 12805378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM.
    Yin W; Rossin A; Clifford JL; Gronemeyer H
    Oncogene; 2006 Jun; 25(26):3735-44. PubMed ID: 16449964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3.
    Yen A; Varvayanis S
    J Cell Physiol; 1995 Jun; 163(3):502-9. PubMed ID: 7775593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest.
    Casini T; Pelicci PG
    Oncogene; 1999 May; 18(21):3235-43. PubMed ID: 10359529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.